A real-world study on clinical predictors of relapse after hospitalized detoxification in a Chinese cohort with alcohol dependence

被引:9
|
作者
Tao, Yu-Jie [1 ,2 ]
Hu, Li [1 ,2 ]
He, Ying [1 ,2 ]
Cao, Bing-Rong [1 ,2 ]
Chen, Juan [1 ,2 ]
Ye, Ying-Hua [1 ,2 ]
Chen, Ting [1 ,2 ]
Yang, Xia [1 ,2 ]
Xu, Jia-Jun [1 ,2 ]
Li, Jing [1 ,2 ]
Meng, Ya-Jing [1 ,2 ]
Li, Tao [1 ,2 ]
Guo, Wan-Jun [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Psychiat Lab, Chengdu, Sichuan, Peoples R China
来源
PEERJ | 2019年 / 7卷
关键词
Alcohol dependence; Relapse; Real-world study; Psychotherapy; Pharmaceutical treatment; RESIDENTIAL-TREATMENT PROGRAMS; RANDOMIZED CONTROLLED-TRIAL; EXTERNAL VALIDITY; INDIVIDUALS; OUTCOMES;
D O I
10.7717/peerj.7547
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. The relapse rate of alcohol dependence (AD) after detoxification is high, but few studies have investigated the clinical predictors of relapse after hospitalized detoxification in real-world clinical practice, especially among Chinese patients. Methods. This longitudinal cohort study followed up 122 AD patients who were discharged from January 1, 2016 to January 30, 2018 from their most recent hospitalization for detoxification. These patients were interviewed by telephone from May 20, 2017, to June 30, 2018, at least 6 months after discharge. During the interview, the relapse were assessed by using a revised Chinese version of the Alcohol Use Disorder Identification Test. Candidate predictors, such as therapeutic modalities during hospitalization and at discharge, medical history data related to alcohol use, and demographic information, were obtained from the medical records in the hospital information system. Results. During the 6-24 months (with a median of 9 months) follow-up period, the relapse rate was 53.3%. Individuals with a college education level and those who had not been treated with the brief comprehensive cognitive-motivational-behavioural intervention (CCMBI) were more likely than their counterparts to relapse after hospitalized detoxification, and their adjusted HRs (95% CIs) were 1.85 (1.09, 3.16) and 2.00 (1.16, 3.46), respectively. The CCMBI use predicted a reduction in the relapse rate by approximately one-fifth. Conclusion. Undergoing the CCMBI during detoxification hospitalization and having less than a college-level education could predict a reduced risk of AD relapse. These findings provide useful information both for further clinical research and for real-world practice.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Nalmefene: clinical and real world evidence in the treatment of alcohol dependence
    Maremmani, I.
    Presta, S.
    Petracca, A.
    Di Nicola, M.
    Maremmani, A. G. I.
    Ruggeri, F.
    Janiri, L.
    JOURNAL OF PSYCHOPATHOLOGY, 2014, 20 (01): : 80 - 91
  • [2] Prevalence and clinical implications of subretinal fluid in retinal diseases: a real-world cohort study
    Park, Jeff
    Felfeli, Tina
    Kherani, Imaan Z.
    Altomare, Filiberto
    Chow, David R.
    Wong, David T.
    BMJ OPEN OPHTHALMOLOGY, 2023, 8 (01):
  • [3] Predicting time to relapse in patients with schizophrenia according to patients' relapse history: a historical cohort study using real-world data in Sweden
    Jorgensen, Kristian Tore
    Bog, Martin
    Kabra, Madhu
    Simonsen, Jacob
    Adair, Michael
    Jonsson, Linus
    BMC PSYCHIATRY, 2021, 21 (01)
  • [4] Predicting time to relapse in patients with schizophrenia according to patients’ relapse history: a historical cohort study using real-world data in Sweden
    Kristian Tore Jørgensen
    Martin Bøg
    Madhu Kabra
    Jacob Simonsen
    Michael Adair
    Linus Jönsson
    BMC Psychiatry, 21
  • [5] Real-world effects of antidepressants for depressive disorder in primary care: population-based cohort study
    De Crescenzo, Franco
    De Giorgi, Riccardo
    Garriga, Cesar
    Liu, Qiang
    Fazel, Seena
    Efthimiou, Orestis
    Hippisley-Cox, Julia
    Cipriani, Andrea
    BRITISH JOURNAL OF PSYCHIATRY, 2024,
  • [6] Real-world annualized relapse rates from contemporary multiple sclerosis clinics in the UK: a retrospective multicentre cohort study
    Athanasios Papathanasiou
    Aimee Hibbert
    Emma Tallantyre
    Katharine Harding
    Adithya Panneer Selvam
    Matthew Morgan
    Charlotte Quainton
    Maryam Talaei
    Tarunya Arun
    Gillian Ingram
    Graham R. Law
    Nikos Evangelou
    Neurological Sciences, 2023, 44 : 3629 - 3635
  • [7] Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data
    Maëlys Touya
    Debra F. Lawrence
    Anne Kangethe
    Lambros Chrones
    Themmi Evangelatos
    Michael Polson
    BMC Psychiatry, 22
  • [8] Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data
    Touya, Maelys
    Lawrence, Debra F.
    Kangethe, Anne
    Chrones, Lambros
    Evangelatos, Themmi
    Polson, Michael
    BMC PSYCHIATRY, 2022, 22 (01)
  • [9] Real-world annualized relapse rates from contemporary multiple sclerosis clinics in the UK: a retrospective multicentre cohort study
    Papathanasiou, Athanasios
    Hibbert, Aimee
    Tallantyre, Emma
    Harding, Katharine
    Selvam, Adithya Panneer
    Morgan, Matthew
    Quainton, Charlotte
    Talaei, Maryam
    Arun, Tarunya
    Ingram, Gillian
    Law, Graham R.
    Evangelou, Nikos
    NEUROLOGICAL SCIENCES, 2023, 44 (10) : 3629 - 3635
  • [10] Real-World Effectiveness of Nirmatrelvir/ Ritonavir and Dexamethasone Among Hospitalized Patients with COVID-19: A Prospective Cohort Study
    Liu, Wei
    Song, Qingkun
    Li, Fang
    Cao, Yu
    Han, Ying
    Wu, Jiangping
    Hu, Zhongjie
    Zhang, Yonghong
    Ma, Yingmin
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 5223 - 5231